|
CN106177903A
|
|
Nalmefene hydrochloride and the pharmaceutical composition of two kinds of active ingredient of reduced glutathion
|
|
CN106748748A
|
|
A kind of Preparation Method And Their Intermediate of Bu Waxitan
|
|
CN106619561A
|
|
Capsule containing alverine citrate
|
|
CN106474086A
|
|
A kind of pharmaceutical composition containing paricalcitol 19-Nor-1,25-dihydroxyvitamin D2
|
|
CN106474054A
|
|
A kind of injection containing nalmefene hydrochloride
|
|
CN106265492A
|
|
A kind of pharmaceutical composition containing paricalcitol 19-Nor-1,25-dihydroxyvitamin D2 and preparation method thereof
|
|
CN104784113A
|
|
Linezolid-containing composition and preparation method thereof
|
|
CN104721223A
|
|
Compound electrolyte injection liquid and preparation method thereof
|
|
CN104644551A
|
|
Hydroxyfasudil-containing pharmaceutical composition for injection
|
|
CN105832683A
|
|
Tablet containing ticagrelor
|
|
CN105616412A
|
|
Composition containing moxifloxacin hydrochloride
|
|
CN105267181A
|
|
Esomeprazole-magnesium-containing enteric pellet capsule
|
|
CN104940152A
|
|
Pharmaceutical composition containing solifenacin succinate
|
|
CN103705448A
|
|
Pharmaceutical composition containing nalmefene hydrochloride for injection
|
|
CN103893138A
|
|
Tablet containing linezolid crystal form III
|
|
CN103896910A
|
|
Synthetic method of duloxetine
|
|
CN103784419A
|
|
Softgel containing calcitriol and preparation method
|
|
CN103724268A
|
|
Celecoxib preparation method
|
|
CN103570639A
|
|
Synthetic method of linezolid
|
|
CN102895178A
|
|
Strong solution-type moxifloxacin hydrochloride injection and preparation method thereof
|
